
Recent filings under Form 13F have been reported by multiple asset management firms, indicating their latest holdings as of the end of the previous quarter. Notable firms that submitted their 13F filings include Knoll Capital Management LLC, Krensavage Asset Management LLC, Ashford Capital Management Inc., Oberndorf William E., and Paradigm Capital Management Inc. Other firms that reported include AWM Investment Company Inc., Frazier Life Sciences Management L.P., Daily Journal Corp., Steelhead Partners LLC, Burgundy Asset Management Ltd., Sylebra Capital LLC, Barrow Hanley Mewhinney & Strauss LLC, and CTC LLC. These filings provide insights into the investment strategies and positions of these firms, particularly in the biotech and technology sectors, as highlighted by recent analyses and tools available for tracking hedge fund investments.

📢 New 13-F filings update! 🔥 Discover the latest biotech stock positions from hedge funds with our updated Hedge Fund Tool. 🧬📊 Don’t miss out on the trends shaping the biotech sector—check it out now! 💡 https://t.co/DqYSx1vfSp #BiotechInvesting #HedgeFunds #13F https://t.co/YVY7wBz7a4
5 Top Tech Stocks Hedge Funds Have Been Bullish On In Q4 (Hint: It's Not Nvidia) According to the latest 13F Heat Map for Technology stocks from WhaleWisdom, these were the five stocks that saw the most significant inflows from institutional investors: 1. The Technology Select… https://t.co/GwmSNLm6be
In case you missed our Non Consensus Investing episode here it is with timestamps⬇️ " Hedge Fund Positioning: 13F Review " Download the 13F document here - https://t.co/JDLycMwBWF (01:12) Hedge Fund Position Analysis (02:46) Key Holdings and Market Trends (04:23) Extracting… https://t.co/TQUox8JHRj